04.06.2021 - Intel Teams with Leidos, Fortanix to Accelerate Clinical Trials

p>What’s New: Leidos and Fortanix are using Intel® Software Guard Extension (Intel® SGX), a unique security technology of Intel® Xeon® processors, to help streamline and accelerate the clinical drug trial process. Leidos provides information technology services for a variety of industries, including life sciences. As clinical trials have become increasingly complex, building systems that can address …... - View Press Release - Visit Intel Corporation